Search Results - "CLERMONT, Allen C"

Refine Results
  1. 1

    Plasma Kallikrein-Kinin System as a VEGF-Independent Mediator of Diabetic Macular Edema by Kita, Takeshi, Clermont, Allen C, Murugesan, Nivetha, Zhou, Qunfang, Fujisawa, Kimihiko, Ishibashi, Tatsuro, Aiello, Lloyd Paul, Feener, Edward P

    Published in Diabetes (New York, N.Y.) (01-10-2015)
    “…This study characterizes the kallikrein-kinin system in vitreous from individuals with diabetic macular edema (DME) and examines mechanisms contributing to…”
    Get full text
    Journal Article
  2. 2

    Hyperglycemia-induced cerebral hematoma expansion is mediated by plasma kallikrein by Flaumenhaft, Robert, Clermont, Allen C, Gao, Ben-Bo, Blair, Price, Feener, Edward P, Liu, Jia, Sinha, Sukanto, Chilcote, Tamie J

    Published in Nature medicine (01-02-2011)
    “…Hyperglycemia is associated with greater hematoma expansion and poor clinical outcomes after intracerebral hemorrhage. We show that cerebral hematoma expansion…”
    Get full text
    Journal Article
  3. 3

    Oral FXIIa inhibitor KV998086 suppresses FXIIa and single chain FXII mediated kallikrein kinin system activation by Clermont, Allen C, Murugesan, Nivetha, Edwards, Hannah J, Lee, Daniel K, Bayliss, Natasha P, Duckworth, Edward J, Pethen, Stephen J, Hampton, Sally L, Gailani, David, Feener, Edward P

    Published in Frontiers in pharmacology (19-12-2023)
    “…The kallikrein kinin system (KKS) is an established pharmacological target for the treatment and prevention of attacks in hereditary angioedema (HAE)…”
    Get full text
    Journal Article
  4. 4

    Reduction of Diabetes-Induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cβ–Null Mice by OHSHIRO, Yuzuru, MA, Ronald C, YASUDA, Yutaka, HIRAOKA-YAMAMOTO, Junko, CLERMONT, Allen C, ISSHIKI, Keiji, YAGI, Kunimasa, ARIKAWA, Emi, KERN, Timothy S, KING, George L

    Published in Diabetes (New York, N.Y.) (01-11-2006)
    “…Reduction of Diabetes-Induced Oxidative Stress, Fibrotic Cytokine Expression, and Renal Dysfunction in Protein Kinase Cβ–Null Mice Yuzuru Ohshiro 1 , Ronald C…”
    Get full text
    Journal Article
  5. 5

    Plasma Kallikrein Mediates Angiotensin II Type 1 Receptor–Stimulated Retinal Vascular Permeability by Phipps, Joanna A, Clermont, Allen C, Sinha, Sukanto, Chilcote, Tamie J, Bursell, Sven-Erik, Feener, Edward P

    Published in Hypertension (Dallas, Tex. 1979) (01-02-2009)
    “…Hypertension is a leading risk factor for the development and progression of diabetic retinopathy and contributes to a variety of other retinal diseases in the…”
    Get full text
    Journal Article
  6. 6
  7. 7

    Plasma kallikrein mediates brain hemorrhage and edema caused by tissue plasminogen activator therapy in mice after stroke by Simão, Fabrício, Ustunkaya, Tuna, Clermont, Allen C., Feener, Edward P.

    Published in Blood (20-04-2017)
    “…Thrombolytic therapy using tissue plasminogen activator (tPA) in acute stroke is associated with increased risks of cerebral hemorrhagic transformation and…”
    Get full text
    Journal Article
  8. 8

    Retinal Blood Flow in Diabetes by Clermont, Allen C., Bursell, Sven-Erik

    “…Objective: This is a review of work focused on characterizing retinal blood flow in diabetes. The review describes results on validation of the methodology for…”
    Get full text
    Journal Article
  9. 9

    Vitreous Proteomics and Diabetic Retinopathy by Walia, Saloni, Clermont, Allen C., Gao, Ben-Bo, Aiello, Lloyd Paul, Feener, Edward P.

    Published in Seminars in ophthalmology (01-11-2010)
    “…Diabetic retinopathy is the major cause of acquired blindness in working-age adults. Studies of the vitreous proteome have provided insights into the etiology…”
    Get full text
    Journal Article
  10. 10

    PM2.5 induces vascular permeability increase through activating MAPK/ERK signaling pathway and ROS generation by Long, Yan-Min, Yang, Xue-Zhi, Yang, Qing-Qing, Clermont, Allen C., Yin, Yong-Guang, Liu, Guang-Liang, Hu, Li-Gang, Liu, Qian, Zhou, Qun-Fang, Liu, Qian S., Ma, Qian-Chi, Liu, Yu-Chen, Cai, Yong

    Published in Journal of hazardous materials (15-03-2020)
    “…[Display omitted] •Vascular permeability is increased upon in-vivo exposure of PM2.5.•The damaged endothelial integrity mediates the disorder of vascular…”
    Get full text
    Journal Article
  11. 11

    Retinal proteome associated with bradykinin-induced edema by Murugesan, Nivetha, Fickweiler, Ward, Clermont, Allen C., Zhou, Qunfang, Feener, Edward P.

    Published in Experimental eye research (01-09-2019)
    “…The plasma kallikrein-stimulated generation of bradykinin (BK) has been implicated in diabetic macular edema (DME). This study characterizes the effects of BK…”
    Get full text
    Journal Article
  12. 12
  13. 13

    Evaluating anesthetic protocols for functional blood flow imaging in the rat eye by Moult, Eric M, Choi, WooJhon, Boas, David A, Baumann, Bernhard, Clermont, Allen C, Feener, Edward P, Fujimoto, James G

    Published in Journal of biomedical optics (01-01-2017)
    “…The purpose of this study is to evaluate the suitability of five different anesthetic protocols (isoflurane, isoflurane-xylazine, pentobarbital,…”
    Get full text
    Journal Article
  14. 14

    Iris Malformation and Anterior Segment Dysgenesis in Mice and Humans With a Mutation in PI 3-Kinase by Solheim, Marie H, Clermont, Allen C, Winnay, Jonathon N, Hallstensen, Erlend, Molven, Anders, Njølstad, Pål R, Rødahl, Eyvind, Kahn, C Ronald

    “…To determine the ocular consequences of a dominant-negative mutation in the p85α subunit of phosphatidylinositol 3-kinase (PIK3R1) using a knock-in mouse model…”
    Get full text
    Journal Article
  15. 15

    Plasma Kallikrein Contributes to Intracerebral Hemorrhage and Hypertension in Stroke-Prone Spontaneously Hypertensive Rats by Guan, Jian, Clermont, Allen C., Pham, Loc-Duyen, Ustunkaya, Tuna, Revenko, Alexey S., MacLeod, A. Robert, Feener, Edward P., Simão, Fabrício

    Published in Translational stroke research (01-04-2022)
    “…Plasma kallikrein (PKa) has been implicated in contributing to hemorrhage following thrombolytic therapy; however, its role in spontaneous intracerebral…”
    Get full text
    Journal Article
  16. 16

    Intraocular hemorrhage causes retinal vascular dysfunction via plasma kallikrein by Liu, Jia, Clermont, Allen C, Gao, Ben-Bo, Feener, Edward P

    “…Retinal hemorrhages occur in a variety of sight-threatening conditions including ocular trauma, high altitude retinopathy, and chronic diseases such as…”
    Get full text
    Journal Article
  17. 17

    Measurement of pulsatile total blood flow in the human and rat retina with ultrahigh speed spectral/Fourier domain OCT by Choi, Woojhon, Baumann, Bernhard, Liu, Jonathan J, Clermont, Allen C, Feener, Edward P, Duker, Jay S, Fujimoto, James G

    Published in Biomedical optics express (01-05-2012)
    “…We present an approach to measure pulsatile total retinal arterial blood flow in humans and rats using ultrahigh speed Doppler OCT. The axial blood velocity is…”
    Get full text
    Journal Article
  18. 18

    Hyperinsulinemia Does Not Change Atherosclerosis Development in Apolipoprotein E Null Mice by Rask-Madsen, Christian, Buonomo, Erica, Li, Qian, Park, Kyoungmin, Clermont, Allen C, Yerokun, Oluwatobi, Rekhter, Mark, King, George L

    “…OBJECTIVE—To determine the contribution of hyperinsulinemia to atherosclerosis development. METHODS AND RESULTS—Apolipoprotein E (Apoe) null mice that had…”
    Get full text
    Journal Article
  19. 19

    Negatively charged silver nanoparticles cause retinal vascular permeability by activating plasma contact system and disrupting adherens junction by Long, Yan-Min, Zhao, Xing-Chen, Clermont, Allen C., Zhou, Qun-Fang, Liu, Qian, Feener, Edward P., Yan, Bing, Jiang, Gui-Bin

    Published in Nanotoxicology (20-04-2016)
    “…Silver nanoparticles (AgNPs) have been extensively used as antibacterial component in numerous healthcare, biomedical and consumer products. Therefore, their…”
    Get full text
    Journal Article
  20. 20